ACC 2022

Bayer

Pharma

At ACC, Bayer presents findings of Kerendia, asundexian

At the ACC meeting, Bayer presented its latest findings on its diabetic kidney cancer drug Kerendia, discovered by pooling two trials.

Kevin Dunleavy Apr 4, 2022 12:47pm

ACC: Lexicon's sotagliflozin can cut stroke, heart attack

Apr 2, 2022 3:37pm